TrialThe Lancet. Infectious diseases2021

Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial.

Mainga Hamaluba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.